In over half of DLBCL, the SHM process appears to misfire and aberrantly target multiple proto-oncogenes implicated in the pathogenesis of lymphoid malignancies (PIM1, PAX5, RhoH/TTF and cMYC)88. This evidence concerns the gene RHOH and diffuse large B-cell lymphoma.